Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Genomic study reveals five subtypes of colorectal cancer

Publish date:: July 3, 2019

Key clinical point: Colorectal cancer can be divided into five DNA methylation subtypes that predict molecular and clinical behavior and may offer future therapeutic targets.

Major finding: The mean age of patients with CpG island methylator phenotype (CIMP)–high colorectal cancer was 75.2 years, compared with 61.9 years for patients with CIMP-negative disease (P less than .0001).

Study details: A genomic study involving 216 unselected colorectal cancers.

Disclosures: The study was funded by the National Health and Medical Research Council, the U.S. National Institutes of Health, Pathology Queensland, and others. The investigators disclosed no conflicts of interest.

Citation:

Fennell L et al. Cell Mol Gastroenterol Hepatol. 2019 Apr 5. doi: 10.1016/j.jcmgh.2019.04.002.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Gastroenterology

Younger adults present with more advanced esophageal adenocarcinoma,

DOACs look safe in elective endoscopic procedures,

Upper GI bleeds in COVID-19 not related to increased mortality,

Cryoballoon, cryospray found equivalent for eradicating Barret’s esophagus,